CompaniesSomerset Pharmaceuticals

Somerset Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

4

As Collaborator

1

Total Enrollment

1,209

By Phase

PHASE4: 3PHASE3: 2

By Status

COMPLETED: 5
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00032929
Hover over trial bars to see details

Recent Trials

NCT00531947Lead Sponsor
Phase IV:Safety and Efficacy of EMSAM in Adolescents With Major Depression
PHASE4Completed
308 participants
Started: Jul 31, 2007 · Completed: Oct 31, 2010
NCT00531596Lead Sponsor
Evaluation of Adhesion and Dermal Tolerability of EMSAM
PHASE4Completed
300 participants
Started: Apr 30, 2007 · Completed: Jul 31, 2007
NCT00532116Lead Sponsor
PK Comparison of 6mg and 12mg EMSAM in Elderly vs. Non-Elderly
PHASE4Completed
32 participants
Started: Apr 30, 2007 · Completed: Aug 31, 2007
NCT00285766Lead Sponsor
Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major Depression
PHASE3Completed
300 participants
Started: Aug 31, 2002 · Completed: Jul 31, 2005
NCT00032929Collaborator
Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1
PHASE3Completed
269 participants
Started: Mar 31, 2001
Related Companies
Mylan
acquired